Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus with carboplatin + paclitaxel as first-line therapy for clear cell ovarian carcinoma (GOG-0268)
jRCT2091220076Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in clear cell ovarian cancer, sponsored by GOG Foundation. Primary endpoint: Progression-free survival. Started Jan 2012; status: completed.
02
Drugs
temsirolimus
03
Conditions
clear cell ovarian cancer
Beyond the preview
Go deeper on jRCT2091220076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220076.